A biotinylated α-enolase peptide
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

α-Enolase (1-19)-biotin Peptide

Item No. 37628

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Synonyms
  • Enolase-1 (1-19)-biotin
MW
2,379.8
Formulation (Request formulation change)
1 mg of lyophilized peptide
UniProt Accession №
P06733
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    1 mg

    $247

    Add
    Cayman Chemical
    Neutrophil Biology Wall Poster

    Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.

    DOWNLOAD NOW
    Product Description

    α-Enolase (1-19)-biotin peptide is a biotinylated form of a 19-amino acid N-terminal peptide fragment of α-enolase, a glycolytic enzyme that catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate.1 α-Enolase also functions as a cell surface receptor for plasminogen on pathogens and activated immune cells, as an oxidative stress protein in endothelial cells, and as a chromatin binding partner to facilitate transcription.2,3,4 α-Enolase is an autoantigen in asthma, Hashimoto's encephalopathy, and rheumatoid arthritis, and has been found in the serum of pediatric patients with juvenile idiopathic arthritis.5,6,7,8 Cayman’s α-Enolase (1-19)-biotin Peptide is intended for use as a negative control in the detection of autoantibodies against citrullinated α-enolase and is the non-citrullinated form of Citrullinated α-Enolase (R8 +R13) (1-19)-biotin Peptide (Item No. 37627).

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Zhu, X., Miao, X., Wu, Y., et al. ENO1 promotes tumor proliferation and cell adhesion mediated drug resistance (CAM-DR) in non-Hodgkin’s lymphomas. Exp. Cell Res. 335(2), 216-223 (2015).

    2. Song, Y., Luo, Q., Long, H., et al. Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma. Mol. Cancer 13, 65 (2014).

    3. Subramanian, A., and Miller, D.M. Structural analysis of α-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene. The Journal of Biological Chemisty 275(8), 5958-5965 (2000).

    4. Hsiao, K.-C., Shih, N.-Y., Fang, H.-L., et al. Surface α-enolase promotes extracellular matrix degradation and tumor metastasis and represents a new therapeutic target. PLoS One 8(7), e69354 (2013).

    5. Nahm, D.-H., Lee, K.-H., Shin, J.-Y., et al. Identification of α-enolase as an autoantigen associated with severe asthma. J. Allergy Clin. Immunol. 118(2), 376-381 (2006).

    6. Moore, T.L., Gillian, B.E., Crespo-Pagnussat, S., et al. Measurement and evaluation of isotypes of anti-citrullinated fibrinogen and anti-citrullinated α-enolase antibodies in juvenile idiopathic arthritis. Clin. Exp. Rheumatol. 32(5), 740-746 (2014).

    7. Yoneda, M., Fujii, A., Ito, A., et al. High prevalence of serum autoantibodies against the amino terminal of α-enolase in Hashimoto’s encephalopathy. J. Neuroimmunol. 185(1-2), 195-200 (2007).

    8. Cong, Y., Wang, L., Peng, R., et al. Timosaponin AIII induces antiplatelet and antithrombotic activity via Gq-mediated signaling by the thromboxane A2 receptor. Sci. Rep. 6, 38757 (2016).